![Impact of continued administration of tolvaptan on cirrhotic patients with ascites | BMC Pharmacology and Toxicology | Full Text Impact of continued administration of tolvaptan on cirrhotic patients with ascites | BMC Pharmacology and Toxicology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40360-018-0277-3/MediaObjects/40360_2018_277_Fig1_HTML.png)
Impact of continued administration of tolvaptan on cirrhotic patients with ascites | BMC Pharmacology and Toxicology | Full Text
![A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/29/10/2458/F4.large.jpg)
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology
![A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology](https://jasn.asnjournals.org/content/29/10/2458/F1.large.jpg)
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology
![Figure 4 from Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan | Semantic Scholar Figure 4 from Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e79fbbd8361e9f9d545bcf4675337690860bf874/6-Figure4-1.png)
Figure 4 from Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan | Semantic Scholar
![PPT - HYPONATREMIA AND THE EMERGING ROLE OF TOLVAPTAN IN CARDIOLOGY PowerPoint Presentation - ID:6968996 PPT - HYPONATREMIA AND THE EMERGING ROLE OF TOLVAPTAN IN CARDIOLOGY PowerPoint Presentation - ID:6968996](https://image3.slideserve.com/6968996/tolvaptan1-l.jpg)
PPT - HYPONATREMIA AND THE EMERGING ROLE OF TOLVAPTAN IN CARDIOLOGY PowerPoint Presentation - ID:6968996
![Tolvaptan, a vasopressin V2 receptor antagonist, is a strong diuretic with a new mechanism of action - YouTube Tolvaptan, a vasopressin V2 receptor antagonist, is a strong diuretic with a new mechanism of action - YouTube](https://i.ytimg.com/vi/G5BtxTTskAM/maxresdefault.jpg)
Tolvaptan, a vasopressin V2 receptor antagonist, is a strong diuretic with a new mechanism of action - YouTube
![Mechanism of action for vasopressin and V2-receptor antagonists. The... | Download Scientific Diagram Mechanism of action for vasopressin and V2-receptor antagonists. The... | Download Scientific Diagram](https://www.researchgate.net/profile/Mitchell-Rosner/publication/233418615/figure/fig1/AS:667830152335360@1536234524053/Mechanism-of-action-for-vasopressin-and-V2-receptor-antagonists-The-binding-of_Q640.jpg)
Mechanism of action for vasopressin and V2-receptor antagonists. The... | Download Scientific Diagram
![Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure | Future Cardiology Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.13.3/asset/images/medium/figure2.gif)